Who Paid My Doc
Joel Pellot Cestero
Neurological Surgery San Juan, PR Medical Doctor
NPI 1295174217 CMS profile 1312997
University District Hospital Bo Monacillos, San Juan, PR 00935
General payments
$200
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Joel Pellot Cestero of San Juan, PR is reported in the CMS Open Payments database as having received $200 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 13th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $118 | 1 | |
| 2019 | General | $81 | 1 |
Beside peers
- Joel Pellot Cestero
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Joel Pellot Cestero were reported at $118. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Joel Pellot Cestero | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $81 | $582 | $138–$3,006 | $163 |
| 2020 | $0 | $294 | $76–$2,174 | $114 |
| 2021 | $0 | $387 | $105–$2,432 | $132 |
| 2022 | $0 | $542 | $139–$2,989 | $149 |
| 2023 | $0 | $534 | $145–$2,697 | $160 |
| 2024 | $0 | $574 | $155–$3,046 | $164 |
| 2025 | $118 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 12 billing codesPaid by Medicare
$11,286
Medicare patients
34
Services billed
47
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Depression | 56% | |
| Diabetes | 53% | |
| Arthritis | 44% | |
| Atrial fibrillation | 35% | |
| Heart failure | 32% | |
| Ischemic heart disease | 32% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in Puerto Rico
Rafael Cardona Duran
Neurological Surgery · Guaynabo, PR
Rodolfo Alcedo
Neurological Surgery · San Juan, PR
David Lozada
Neurological Surgery · Manati, PR
Samuel Estronza-Ojeda
Neurological Surgery · Caguas, PR
Yadira Dacosta
Neurological Surgery · Humacao, PR
Rafael Rodriguez-Mercado
Neurological Surgery · San Juan, PR
Related records
Neurological Surgery in Puerto Rico
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Puerto Rico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.